While these loci may hold biological plausibility (especially IL6R, given the use of IL-6 receptor inhibitors in the treatment of COVID-19), these associations were driven by two smaller cohorts (Genentech and Vanda, S5 Fig). The gene discussed is IL6R; the disease is COVID-19.